Pediatric Heart Network

Pediatric Heart Network
Name	Pediatric Heart Network
Formation	2001
Type	Clinical research network
Region served	United States, Canada

Pediatric Heart Network. The Pediatric Heart Network is a collaborative clinical research consortium established and funded by the National Heart, Lung, and Blood Institute. Its primary mission is to improve outcomes and quality of life for children and adolescents with congenital or acquired heart disease through the design and conduct of multi-center clinical studies. The network brings together leading pediatric cardiology centers, core laboratories, and a data coordinating center to address critical questions in the field that individual institutions cannot answer alone.

History and Formation

The network was formally launched in 2001 by the National Institutes of Health as part of a strategic initiative to enhance pediatric cardiovascular research. Its creation was driven by a recognized need for rigorous, large-scale trials to inform evidence-based practice for complex conditions like hypoplastic left heart syndrome and tetralogy of Fallot. Key figures in its development included leadership from the NHLBI and pioneering pediatric cardiologists from institutions such as the Children's Hospital of Philadelphia and Boston Children's Hospital. The formation built upon earlier collaborative efforts and was influenced by the success of adult networks like the Cardiovascular Health Study.

Research Focus and Objectives

The network's scientific agenda is centered on comparative effectiveness research, longitudinal outcomes studies, and interventional trials across the spectrum of pediatric heart disease. Core objectives include optimizing surgical and catheter-based interventions, improving neurodevelopmental outcomes, and managing heart failure in young patients. Specific disease targets have included single ventricle physiology, Marfan syndrome, and cardiomyopathy. The research framework emphasizes a translational approach, aiming to bridge discoveries from basic science, such as studies in genetics or myocardial function, directly to clinical care paradigms.

Clinical Trials and Studies

The network has conducted numerous landmark trials that have directly influenced clinical guidelines. Major studies include the **Single Ventricle Reconstruction Trial**, which compared surgical shunt types for hypoplastic left heart syndrome, and the **Pediatric Heart Network Infant Single Ventricle Trial**, which evaluated nutritional strategies. Other significant protocols have investigated the management of aortic aneurysm in Marfan syndrome, the treatment of Fontan-associated liver disease, and exercise performance in patients with tetralogy of Fallot. These trials often utilize core laboratories for standardized analysis of echocardiography, magnetic resonance imaging, and biomarker data.

Organizational Structure and Governance

Governance is overseen by a Steering Committee composed of principal investigators from each clinical site and the Data Coordinating Center, alongside representatives from the NHLBI. Key operational components include Protocol Review and Monitoring Committees, an independent Data and Safety Monitoring Board, and ancillary study subcommittees. The Data Coordinating Center, historically based at institutions like the New England Research Institutes, manages trial design, statistical analysis, and data integrity. This structure ensures rigorous scientific review and adherence to regulations set by the Food and Drug Administration.

Member Institutions and Collaborations

The consortium comprises a rotating group of core clinical centers, typically including major academic children's hospitals. Consistent participants have included the Children's Hospital of Philadelphia, Boston Children's Hospital, Texas Children's Hospital, Cincinnati Children's Hospital Medical Center, and Hospital for Sick Children in Toronto. The network actively collaborates with other research entities such as the Congenital Heart Surgeons' Society, the American Heart Association, and the Pediatric Cardiac Intensive Care Society. These partnerships extend its reach into registries like the Society of Thoracic Surgeons Congenital Heart Surgery Database.

Impact and Key Findings

Research from the network has profoundly shaped pediatric cardiology practice. Its trials have defined standard-of-care surgical approaches for hypoplastic left heart syndrome, leading to changes in recommendations from the American College of Cardiology. Key findings have elucidated risk factors for neurodevelopmental delay, validated non-invasive imaging biomarkers for ventricular function, and established evidence for angiotensin-converting enzyme inhibitor use in specific populations. The network's biorepositories and longitudinal data continue to support ancillary studies, contributing to a deeper understanding of the long-term outcomes for survivors of congenital heart disease into adulthood.

Category:Medical research organizations Category:Pediatrics Category:Cardiology